Societies

The Final Episode of the APAC Lung Cancer Consensus Video Series – ASPIRE for Lung Cancer

ASPIRE for Lung CancerLinkedIn

Sep 2, 2025, 10:12

The Final Episode of the APAC Lung Cancer Consensus Video Series – ASPIRE for Lung Cancer

ASPIRE for Lung Cancer shared a post on LinkedIn:

“The Final Episode of the APAC Lung Cancer Consensus Video Series

In this final chapter, we hear from Dr Sita Andarini, Associate Professor at the University of Indonesia and Head of Thoracic Oncology at the Indonesian Society of Respirology. A leading voice in the lung cancer field, Dr. Andarini also serves as Head of the Lung Cancer Assembly of the Asian Pacific Society of Respirology and is deeply involved in advancing research, policy, and patient care across the region.

Key highlights from Dr. Andarini include:

The urgent challenge of lung cancer in Indonesia, which often affects younger patients and is detected at late stages
The role of advocacy in shaping policy and expanding access to lung cancer innovation
The need for cross-sector collaboration, from hospitals and clinicians to health authorities and communities, to address disparities in access, stigma, and survivorship

Her message is a powerful call to turn collaboration into tangible, local impact, ensuring that every step of the patient journey, from screening and prevention to survivorship, is supported by responsive, well-executed national policy.

While this series concludes, the work it represents continues. The APAC Lung Cancer Consensus has brought together diverse perspectives to identify shared priorities. From strengthening screening and early detection, to addressing stigma, to ensuring survivors are supported, the future of lung cancer care in the APAC region depends on collective action.

We extend our deepest gratitude to OncoDaily for their invaluable partnership and support in producing this video series, and to all the experts, advocates, and partners who contributed their voices. This is not the end of the conversation, but the beginning of deeper collaboration to deliver better outcomes for every lung cancer patient across the region.”